Researcher.Life Logo

European Pharmaceutical Law Review : Impact Factor & More

eISSN: 2511-7181pISSN: 2511-7157

Key Metrics

H-Index
2
SJR
Q4Law
Recommended pre-submission checks
Powered by Paperpal by Editage

European Pharmaceutical Law Review Journal Specifications

Indexed in the following public directories

  • Scopus Scopus
  • SJR SJR
Overview
Publisher Lexxion Verlagsgesellschaft mbH

Planning to publish in European Pharmaceutical Law Review ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in European Pharmaceutical Law Review

New Clinical Trial Rules in the EU: A Practical Overview of the Upcoming Regulation
  • 1 Jan 2021
  • European Pharmaceutical Law Review
Pharmaceutical Advertising in Digital Media: A Danish Perspective
  • 1 Jan 2021
  • European Pharmaceutical Law Review
Jurisdiction
  • 1 Jan 2021
  • European Pharmaceutical Law Review
Are You AI’S Favourite? EU Legal Implications of Biased AI Systems in Clinical Genetics and Genomics
  • 1 Jan 2021
  • European Pharmaceutical Law Review
Does an Initially Authorised Combination Medicinal Product and a Later Authorised Single Component of that Combination Belong to the Same Global Marketing Authorization? - The Tecfidera® Judgment of the General Court in Case T-611/18
  • 1 Jan 2021
  • European Pharmaceutical Law Review
New Clinical Trial Rules in the EU: A Practical Overview of the Upcoming Regulation
  • 1 Jan 2021
  • European Pharmaceutical Law Review
Pharmaceutical Advertising in Digital Media: A Danish Perspective
  • 1 Jan 2021
  • European Pharmaceutical Law Review
Jurisdiction
  • 1 Jan 2021
  • European Pharmaceutical Law Review
Are You AI’S Favourite? EU Legal Implications of Biased AI Systems in Clinical Genetics and Genomics
  • 1 Jan 2021
  • European Pharmaceutical Law Review
Does an Initially Authorised Combination Medicinal Product and a Later Authorised Single Component of that Combination Belong to the Same Global Marketing Authorization? - The Tecfidera® Judgment of the General Court in Case T-611/18
  • 1 Jan 2021
  • European Pharmaceutical Law Review

FAQs on European Pharmaceutical Law Review